Siliq Market 2026 advancing psoriasis treatment

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Siliq Market At The End Of The 2026–2030 Forecast Period?

Historical growth was driven by the rising incidence of moderate to severe plaque psoriasis, the insufficient effectiveness of conventional systemic therapies, the increasing adoption of biologics by dermatologists, the expansion of specialty dermatology clinics, and improved diagnosis rates.

The projected growth during the forecast period is propelled by several factors, including the escalating demand for advanced biologics, a heightened emphasis on managing diseases over the long term, the broadening scope of personalized immunology treatments, expanding investments in inflammatory disease research, and enhanced patient accessibility to specialized therapies.

Prominent trends expected within the forecast timeframe involve the increasing uptake of targeted biologic therapies, an expanded utilization of IL-17 pathway inhibitors, a greater concentration on individualized psoriasis treatment, the broadening reach of specialty pharmacy distribution, and improved oversight of treatment results.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20265&type=smp

Which Market Drivers Are Supporting The Expansion Of The Siliq Market?

The increasing incidence of skin disease is expected to drive the expansion of the siliq market in the future. Skin disease encompasses a wide array of conditions impacting the skin’s structure, function, or appearance, often stemming from infections, inflammation, genetic factors, autoimmune disorders, or environmental exposures. The rising prevalence of these conditions is linked to factors such as environmental shifts, escalating pollution levels, greater sun exposure, genetic predispositions, and lifestyle elements like poor diet and stress. Siliq offers advantages in treating skin diseases, particularly moderate to severe plaque psoriasis, by targeting specific immune system pathways to lessen inflammation, enhance skin appearance, and relieve symptoms such as redness, scaling, and itching. For instance, the American Cancer Society, a US-based non-profit organization dedicated to eliminating cancer, projected 108,270 reported cases of skin cancer in January 2024, marking a 3.2% increase from the 104,930 cases recorded in 2023. Consequently, the rising prevalence of skin disease is stimulating growth in the siliq market. The expanding geriatric population is anticipated to fuel the growth of the Siliq market moving forward. The term “geriatric population” typically refers to individuals aged 65 years or older, though this age range can differ based on context or healthcare standards. This demographic is growing due to increased life expectancy, advancements in healthcare, and declining birth rates, resulting in a larger proportion of older individuals globally. Siliq is beneficial for the geriatric population by offering an effective treatment for moderate to severe plaque psoriasis, helping older adults manage symptoms and improve skin health, especially when they might have limited treatment options due to age-related health concerns. For example, in July 2024, the UK Parliament’s House of Commons Library, a UK-based government administration, reported that in 2022, the UK had 12.7 million individuals aged 65 and above, constituting 19% of the total population. This figure is projected to rise to 22.1 million, or 27% of the population, by 2072. Thus, the growing geriatric population is a key driver for the siliq market.

What Segment Types Make Up The Siliq Market?

The siliq market covered in this report is segmented –

1) By Clinical Indication: Moderate To Severe Plaque Psoriasis, Other Indications

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies

3) By End-User: Hospitals, Specialty Clinics, Home Care Settings

Who Are The Key Players Driving Competition In The Siliq Market?

Major companies operating in the siliq market are Valeant Pharmaceuticals International Inc.

Read the full siliq market report here:

https://www.thebusinessresearchcompany.com/report/siliq-global-market-report

How Is The Siliq Market Distributed Across Key Geographic Regions?

North America was the largest region in the siliq market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the siliq market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Siliq Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20265&type=smp

Browse Through More Reports Similar to the Global Siliq Market 2026, By The Business Research Company

In Silico Clinical Trials Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-silico-clinical-trials-global-market-report

Silanes Market Report 2026

https://www.thebusinessresearchcompany.com/report/silanes-global-market-report

Automotive Silicone Market Report 2026

https://www.thebusinessresearchcompany.com/report/automotive-silicone-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795